Your session is about to expire
← Back to Search
PRAX-222 for Epileptic Encephalopathy
Study Summary
This trial will study the effects of PRAX-222 on pediatric patients (2-18) with a rare brain disorder called DEE.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I weigh at least 10 kg.My epilepsy or developmental disorder is not caused by known genetic changes outside of the SCN2A gene.I have a confirmed SCN2A variant from an accredited lab test.I am taking more than two medications for seizures that block sodium channels.
- Group 1: Preliminary Safety
- Group 2: Dose Escalation - PRAX-222
- Group 3: Dose Escalation - Placebo
- Group 4: Optional Dose Escalation - PRAX-222
- Group 5: Optional Dose Escalation - Placebo
- Group 6: Confirmatory Dosing - PRAX-222
- Group 7: Confirmatory Dosing - Placebo
- Group 8: Open-label PRAX-222
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor open to individuals aged eighty or above?
"This trial is looking for candidates aged between 2 and 18 years."
Who qualifies for entry into this trial?
"In order to be eligible for the trial, participants must have epilepsy and range in age from 2-18. Sixty individuals are required for recruitment into this study."
Is enrollment still taking place for this clinical experiment?
"According to clinicaltrials.gov, the enrolment process for this medical trial is ongoing. The study was established on 1st February 2023 and it has undergone subsequent revisions as of 10th February 2023."
How many volunteers are being recruited for this medical research?
"Affirmative. According to the clinicaltrials.gov page, this medical trial is currently seeking participants, and was first posted on February 1st 2023 with most recent edits taking place on February 10th of that same year. 60 patients are being enrolled across a single site."
Share this study with friends
Copy Link
Messenger